BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
12 results:

  • 1. The Role of Human Endogenous Retrovirus (HERV)-K119
    Ko EJ; Kim MH; Kim DY; An H; Leem SH; Choi YH; Kim HS; Cha HJ
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958549
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy.
    Nikkhoi SK; Li G; Eleya S; Yang G; Vandavasi VG; Hatefi A
    Front Immunol; 2022; 13():1039969. PubMed ID: 36685519
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience.
    Pauly N; Baert T; Schmutzler R; du Bois A; Schneider S; Rhiem K; Schömig-Markiefka B; Siemanowski J; Heikaus S; Traut A; Heitz F; Prader S; Ehmann S; Harter P; Ataseven B
    Arch Gynecol Obstet; 2021 Oct; 304(4):975-984. PubMed ID: 33710393
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The efficient profiling of serum N-linked glycans by a highly porous 3D graphene composite.
    Niu H; Li X; Peng J; Zhang H; Zhao X; Zhou X; Yu D; Liu X; Wu R
    Analyst; 2019 Sep; 144(17):5261-5270. PubMed ID: 31364612
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risks of Breast, ovarian, and Contralateral Breast cancer for BRCA1 and BRCA2 Mutation Carriers.
    Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H
    JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with ovarian cancer.
    Flanagan JM; Wilson A; Koo C; Masrour N; Gallon J; Loomis E; Flower K; Wilhelm-Benartzi C; Hergovich A; Cunnea P; Gabra H; Braicu EI; Sehouli J; Darb-Esfahani S; Vanderstichele A; Vergote I; Kreuzinger C; Castillo-Tong DC; Wisman GBA; Berns EM; Siddiqui N; Paul J; Brown R
    Clin Cancer Res; 2017 May; 23(9):2213-2222. PubMed ID: 27663594
    [No Abstract]    [Full Text] [Related]  

  • 7. Molecular Pathways: Targeting DNA Repair Pathway Defects Enriched in Metastasis.
    Corcoran NM; Clarkson MJ; Stuchbery R; Hovens CM
    Clin Cancer Res; 2016 Jul; 22(13):3132-7. PubMed ID: 27169997
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Successful en bloc venous resection with reconstruction and subsequent radiotherapy for 2 consecutive recurrences of intravenous leiomyoma--a case report.
    Zhang Y; Clark LH; Sheng X; Zhou C
    BMC Cancer; 2016 Jan; 16():6. PubMed ID: 26739818
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
    Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O
    J BUON; 2013; 18(1):261-7. PubMed ID: 23613414
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.
    Santegoets SJ; Turksma AW; Suhoski MM; Stam AG; Albelda SM; Hooijberg E; Scheper RJ; van den Eertwegh AJ; Gerritsen WR; Powell DJ; June CH; de Gruijl TD
    J Transl Med; 2013 Feb; 11():37. PubMed ID: 23402380
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
    Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy.
    Valerius T; Repp R; de Wit TP; Berthold S; Platzer E; Kalden JR; Gramatzki M; van de Winkel JG
    Blood; 1993 Aug; 82(3):931-9. PubMed ID: 7687898
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.